Chemoinformaics analysis of 1-Caffeoyl-5-feruloyl quinic acid
| Molecular Weight | 530.482 | nRot | 8 |
| Heavy Atom Molecular Weight | 504.274 | nRig | 23 |
| Exact Molecular Weight | 530.142 | nRing | 3 |
| Solubility: LogS | -2.279 | nHRing | 0 |
| Solubility: LogP | 1.647 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 12 |
| nHA | 11 | APOL | 70.3806 |
| nHD | 6 | BPOL | 33.8954 |
| QED | 0.163 |
| Synth | 4.113 |
| Natural Product Likeliness | 1.724 |
| NR-PPAR-gamma | 0.976 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.634 |
| HIA | 0.95 |
| CACO-2 | -6.095 |
| MDCK | 0.0000116 |
| BBB | 0.145 |
| PPB | 0.991626 |
| VDSS | 0.216 |
| FU | 0.0166382 |
| CYP1A2-inh | 0.049 |
| CYP1A2-sub | 0.063 |
| CYP2c19-inh | 0.065 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0.354 |
| CYP2c9-sub | 0.828 |
| CYP2d6-inh | 0.023 |
| CYP2d6-sub | 0.192 |
| CYP3a4-inh | 0.11 |
| CYP3a4-sub | 0.067 |
| CL | 4.505 |
| T12 | 0.958 |
| hERG | 0.028 |
| Ames | 0.018 |
| ROA | 0.07 |
| SkinSen | 0.59 |
| Carcinogencity | 0.142 |
| EI | 0.014 |
| Respiratory | 0.029 |
| NR-Aromatase | 0.525 |
| Antiviral | Yes |
| Prediction | 0.82617 |